Delivery Order SPE2DB24D3013-SPE2DB25FFQBK
- Not listed
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for FOTIVDA 1.34 mg capsules (21-count). This contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with a completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule supply (21-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of FOTIVDA 0.89 mg capsules (21 count), with a ceiling value of $32,270.40 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $30,841.16 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 21 capsules of the pharmaceutical Fotivda at 1.34 mg per capsule. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a firm fixed price of $16,135.20 and a period of performance extending to July 3, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- The Defense Logistics Agency (DLA) awarded a $33,405.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgel capsules (30-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a delivery order under...
- The Defense Logistics Agency awarded a $10,218.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Tavneos 10 mg, a pharmaceutical product for federal medical procurement needs. The contract is non-set-aside and competitively awarded, with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of June 17, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials under firm fixed price terms. The contract is non-competitive and was executed on August 8, 2025, with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,389.72 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials. This firm fixed price delivery order, issued on September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance will be...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,987.15 for 180 mg vials of Trodelvy, a pharmaceutical product used in cancer treatment. The award, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with firm fixed-price pricing terms. This delivery...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQBKDelivery Order
The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for Fotivda 1.34 mg capsules (21-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The SPE2DX contract enables the company to fulfill pharmaceutical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. The current award for Fotivda—an oral medication used in oncology treatment—exemplifies AmerisourceBergen's role as a prime vendor in the DLA's Medical Supply Chain, delivering specialized pharmaceutical products to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 9/2/25 |